Viemed Healthcare (VMD) Enterprise Value (2019 - 2026)

Viemed Healthcare (VMD) has reported Enterprise Value for 8 consecutive years, with $425.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Enterprise Value rose 66.49% year-over-year to $425.5 million; the trailing twelve-month figure through Jun 2026 stood at $425.5 million (up 66.49% YoY), and the FY2025 full-year result was $271.0 million, down 9.14% from the prior year.
• Enterprise Value grew to $425.5 million in Q2 2026 per VMD's latest filing, from $347.1 million in the prior quarter.
• Across five years, Enterprise Value topped out at $425.5 million in Q2 2026 and bottomed at $166.4 million in Q1 2022.
• Historically, Enterprise Value has averaged $282.5 million across 5 years, with a median of $273.4 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Enterprise Value slumped 54.95% in 2022, then soared 108.01% in 2023.
• Over 5 years, Enterprise Value stood at $270.7 million in 2022, then grew by 6.9% to $289.4 million in 2023, then advanced by 3.03% to $298.2 million in 2024, then decreased by 9.14% to $271.0 million in 2025, then soared by 57.02% to $425.5 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered $425.5 million, $347.1 million, and $271.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.